- Reaction score
- 509
No, because it atrophies the testicles and leads to bone density loss without estradiol while bica doesn'tBecause it is too feminizing? I am not even sure how they calculate e2 levels with the receptor-occupier meds but with MPA, there's not really an issue with that. I think what has happened is that for trans females, MPA has become the breast med while spironolactone is the overall AA in a person's protocol. Cause they used to use MPA all of the time for feminization before these receptor-blocking meds became so popular.